Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.13
  • 52 Week Low: 3.20
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 63,583
  • Market Cap: £4.30m
  • RiskGrade: 435

Latest ShareCast News

ValiRx inks deal with Dundee Drug Discovery Unit

By Josh White

Date: Monday 12 Feb 2024

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Valirx Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.13
52 Week Low 3.20
Volume 63,583
Shares Issued 132.35m
Market Cap £4.30m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.71% below the market average17.71% below the market average17.71% below the market average17.71% below the market average17.71% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
94.35% below the market average94.35% below the market average94.35% below the market average94.35% below the market average94.35% below the market average
89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:21 8,692 @ 3.20p
16:07 11,683 @ 3.20p
14:31 1,000 @ 3.20p
13:02 6 @ 3.20p
12:41 5,256 @ 3.20p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page